1. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13: 1502-8.
2. Gorham ED, Garland CF, Garlanf FC, et al. Optimal vitamin D status for colorectal cancer prevention : a quantitative meta analysis. Am J Prev Med 2007 ; 32 : 210-6
3. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer pooled analysis. J Steroid Biochem Mol Biol 2007; 103: 708-11.
4. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-91.
5. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-96.
6. Ng K, Meyerhardt JA, Wu K et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26: 2984-91.
7. Giovannucci E, Liu Y, Hollis BW et al. 25 hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008; 168: 1174-80.
8. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-9.
9.Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-42.
10. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple schlerosis. JAMA 2006; 296: 2832-8.
11. Munger KL, DeLorenze GN, Levin LI, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-5.
12. Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72–77.
13. Costabender KH, Feskanich D, Holmes M, et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rgeum Dis 2008; 67: 530-5.
14 Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-3.
15. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and ß cell dysfunction. Am J Clin Nutr 2004; 79: 820-5.
16. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-6.
17. Autier P, Gandini S. Vitamin D supplementation and total moratlity. A meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-7.
18. Visser M, Deeg DJH, Puts Mte, Seidell JC, Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006; 84: 616-22.
19. Poole AR, Nelson F, Hollander A, et al. Collagen II turnover in joint diseases. Acta Orthop Scand 1995; 266: 88-91.
20. Lane NE, Gore LR, Cummings SR, et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis : a longitudinal study. Study of Osteoporotic Fractures. Arthritis Rheum 1999; 42: 854-60.
21. Felson DT, Niu J, Clancy M, et al. Low levels of vitamin D and worsening of knee osteoarthritis. Results of two longitudinal studies. Arthritis Rheum 2007; 56: 129-136.
22. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008 ; 168 : 771-772.
23. Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari. Association between serum concentrations of 25-hydroxyvitamin D and periodontal disease in the US population. Am J Clin Nutr 2004; 80: 108-13.
En 5 points
Obésité : suivi d’un patient sous aGLP-1
Cas clinique
La fasciite nécrosante
Mise au point
La périménopause
Mise au point
La sclérose en plaques